###begin article-title 0
Suppressive activity of tiotropium bromide on matrix metalloproteinase production from lung fibroblasts in vitro
###end article-title 0
###begin p 1
###xml 0 10 0 10 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Disclosure</bold>
Disclosure
###end p 1
###begin p 2
The authors report no conflicts of interest in this work.
###end p 2
###begin title 3
Background
###end title 3
###begin p 4
Chronic obstructive pulmonary disease (COPD) is characterized by airway remodeling with an accumulation of inflammatory cells. There is also increasing evidence that metalloproteinases (MMPs) may contribute to the pathogenesis of COPD, but the influence of agents that used for the treatment of COPD is not well understood.
###end p 4
###begin title 5
Objective
###end title 5
###begin p 6
###xml 58 59 58 59 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sub>
We evaluated whether tiotropium bromide hydrate (TBH), a M3 muscarinic receptor antagonist, could inhibit MMP production from lung fibroblasts (LFs) in response to tumor necrosis factor (TNF)-alpha stimulation.
###end p 6
###begin title 7
Methods
###end title 7
###begin p 8
###xml 95 96 95 96 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">5</sup>
###xml 57 65 <span type="species:ncbi:9606">patients</span>
LFs were established from normal lung tissues taken from patients with lung tumors. LFs (5 x 105 cells/ml) were stimulated with TNF-alpha in the presence of various concentrations of TBH. After 24 h, culture supernatants were obtained and assayed for the levels of MMPs and tissue inhibitor of metalloproteinases (TIMPs) by ELISA. The influence of TBH on mRNA expression of MMPs and TIMPs in 4 h-cultured cells was also examined by real-time RT-PCR. Furthermore, nuclear factor-kappaB (NF-kappaB) and activator protein-1 (AP-1) in LFs treated with TBH for 4 h was examined by ELISA.
###end p 8
###begin title 9
Results
###end title 9
###begin p 10
TBH at more than 15 pg/ml inhibited the production of MMP-2 from LFs after TNF-alpha stimulation, whereas TIMP-1 and TIMP-2 production was scarcely affected by TBH through the suppression of both mRNA expression and transcription factor, NF-kappaB, activation in LFs induced by TNF-alpha stimulation.
###end p 10
###begin title 11
Conclusion
###end title 11
###begin p 12
These results suggest that the attenuating effect of TBH on MMP-2 production from LFs induced by inflammatory stimulation may be additional beneficial therapeutic effects not directly relating to its bronchodilatory effects.
###end p 12
###begin title 13
Introduction
###end title 13
###begin p 14
###xml 316 332 316 332 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b13-copd-3-781">Hamid et al 2004</xref>
###xml 334 349 334 349 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b15-copd-3-781">Hogg et al 2004</xref>
###xml 351 363 351 363 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b20-copd-3-781">Jeffery 2004</xref>
###xml 217 225 <span type="species:ncbi:9606">patients</span>
Chronic obstructive pulmonary disease (COPD) is well accepted to be attributed to long-term exposure to toxic gases and particles, most often related to cigarette smoking. Histological observations of lung tissues of patients with COPD revealed the presence of the airway remodeling with the inflammatory responses (Hamid et al 2004; Hogg et al 2004; Jeffery 2004).
###end p 14
###begin p 15
###xml 57 59 57 59 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2+</sup>
###xml 66 68 66 68 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2+</sup>
###xml 350 367 350 367 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b28-copd-3-781">Murphy et al 1992</xref>
###xml 369 386 369 386 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b14-copd-3-781">Herouy et al 2001</xref>
###xml 711 729 711 729 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b32-copd-3-781">Ohnishi et al 1998</xref>
###xml 731 749 731 749 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b6-copd-3-781">Demedts et al 2005</xref>
###xml 751 769 751 769 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b23-copd-3-781">Lagente et al 2005</xref>
###xml 771 789 771 789 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b2-copd-3-781">Baraldo et al 2007</xref>
###xml 987 1005 987 1005 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b5-copd-3-781">Cataldo et al 2000</xref>
###xml 1007 1022 1007 1022 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b21-copd-3-781">Kang et al 2003</xref>
###xml 1024 1043 1024 1043 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b1-copd-3-781">Babusyte et al 2007</xref>
###xml 559 564 <span type="species:ncbi:9606">human</span>
Matrix metalloproteinases (MMPs) are a large family of Zn2+ and Ca2+ dependent proteolytic enzymes, which are secreted by a wide variety of cells (eg, inflammatory cells, epithelial cells, and fibroblasts, etc) and essential for tissue remodeling, and have the ability to degrade various components of the extracellular matrix and basement membrane (Murphy et al 1992; Herouy et al 2001). They are accepted to be implicated in normal physiological tissue remodeling, inflammation, and tumor spread. It is widely recognized that many MMPs are expressed in the human lungs, and there is compelling evidence linking MMPs to small airway tissue remodeling, which is the most important histological finding of COPD (Ohnishi et al 1998; Demedts et al 2005; Lagente et al 2005; Baraldo et al 2007). It is also reported that levels of MMPs in both lung tissues and bronchoalveolar lavage fluids, including sputum, increase as lung function worsens and the degree of airway remodeling increases (Cataldo et al 2000; Kang et al 2003; Babusyte et al 2007). Although these reports may suggest that MMPs seem to be good candidates for possible therapeutic targets in the COPD treatment, there is little evidence showing the influence of the agents that used for COPD treatment on MMPs.
###end p 15
###begin p 16
###xml 83 101 83 101 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b37-copd-3-781">Rodrigo et al 2007</xref>
###xml 206 207 206 207 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1</sub>
###xml 210 211 210 211 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 218 219 218 219 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sub>
###xml 279 280 279 280 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sub>
###xml 302 312 302 312 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b9-copd-3-781">Disse 2001</xref>
###xml 422 441 422 441 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b4-copd-3-781">Casaburi et al 2002</xref>
###xml 443 461 443 461 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b43-copd-3-781">Vincken et al 2002</xref>
###xml 463 480 463 480 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b10-copd-3-781">Dusser et al 2006</xref>
###xml 615 631 615 631 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b13-copd-3-781">Hamid et al 2004</xref>
###xml 633 650 633 650 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b12-copd-3-781">Gosens et al 2005</xref>
###xml 884 892 884 892 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 412 420 <span type="species:ncbi:9606">patients</span>
Tiotropium bromide hydrate (TBH), the first choice agent in the treatment of COPD (Rodrigo et al 2007), is a once-daily inhaled anticholinergic bronchodilator, which binds to muscarinic receptor subtypes (M1, M2, and M3), and exhibits a long duration of action due to prolonged M3 receptor antagonism (Disse 2001). There is much evidence that long-term administration of TBH improves the clinical status of COPD patients (Casaburi et al 2002; Vincken et al 2002; Dusser et al 2006). Although experimental evidence showed that TBH could protect airway smooth muscle remodeling, which is observed in COPD and asthma (Hamid et al 2004; Gosens et al 2005), the influence of TBH on the production of MMP, which is the most important enzymes for remodeling, is not fully understood. In the present study, therefore, we examined the influence of TBH on MMPs production from lung fibroblasts in vitro.
###end p 16
###begin title 17
Materials and methods
###end title 17
###begin title 18
Agent
###end title 18
###begin p 19
###xml 184 190 <span type="species:ncbi:9913">bovine</span>
TBH was extracted from inhalable powders for therapeutic use that contained 22.5 mug TBH and 32.5 mug lactose. The powder was dissolved in RPMI-1640 medium supplemented with 10% fetal bovine serum (RPMI-FCS) in a volume of 5.0 ml. This solution was then sterilized by passing through 0.2 mum filters and stored at 4 degreesC as a stock solution until used. All dilutions used in this study were prepared from this stock solution by diluting with RPMI-FCS. To use the medium for control, 32.5 mug lactose (Sigma Chemicals, Co., Ltd, St Louis, MO, USA) was dissolved in 5.0 ml RPMI-FCS, sterilized, diluted with RPMI-FCS in a similar manner. Recombinant TNF-alpha (preservative-free) was purchased from Chemicon International, Inc. (Temecula, CA, USA) and diluted with RPMI-FCS to give a concentration of 50.0 ng/ml.
###end p 19
###begin title 20
Cell source and induction of fibroblasts
###end title 20
###begin p 21
###xml 372 373 372 373 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 572 573 572 573 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 766 767 760 761 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">5</sup>
###xml 910 927 904 921 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b41-copd-3-781">Suzaki et al 2003</xref>
###xml 1103 1120 1097 1114 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b41-copd-3-781">Suzaki et al 2003</xref>
###xml 20 28 <span type="species:ncbi:9606">patients</span>
Tissue samples from patients without lung fibrosis or COPD were obtained from healthy tissue area during pneumonectomy for tumor resection from a tumor-free area. All donors (3 female, 43-71 years; 2 male, 41 and 71 years) were given a written informed consent, which was approved by the Ethics Committee of Showa University. The diced tissue specimens (approximately 1 mm2) were plated at a density of 10 pieces in 100 mm tissue culture dishes and covered with a cover slip adhered to the dishes. The dishes were then at placed in a humidified atmosphere containing 5% CO2 37 degreesC. When a monolayer of fibroblast-like cells was found to be confluent, the explanted tissues were removed. The cells were then trypsinized, and replated at a concentration of 5 x 105 cells/ml into 100 mm tissue culture dishes with a final volume of 10.0 ml. Subsequently, the cells were split 1:2 at confluence and passaged (Suzaki et al 2003). The cells were characterized with antibodies against vimentine, cytokeratin and fibronectine, using fluorescent microscopy (Model No. IX 70, OLYMPAS Co., Ltd, Tokyo, Japan; Suzaki et al 2003), and the fibroblast purity was more than 99% and used as lung-derived fibroblasts (LFs). LFs at six to seven passages were used for the following experiments.
###end p 21
###begin title 22
Cell culture
###end title 22
###begin p 23
###xml 139 140 139 140 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">5</sup>
LFs were washed several times with RPMI-FCS, introduced into each well of 24-well culture plates in triplicate at a concentration of 5 x 105 cells/ml in a volume of 1.0 ml. The cells were stimulated with 25.0 ng/ml TNF-alpha in the presence of various concentrations of TBH in a final volume of 2.0 ml. After 24 h, the culture supernatants were removed, and stored at -40 degreesC until used. In cases of examining transcription factor activation and mRNA expression, cells were cultured in a similar manner for 4 h and stored at -80 degreesC until used. In all cases, TBH was added to cell cultures 2 h before the stimulation with TNF-alpha.
###end p 23
###begin title 24
Assay for MMP and TIMP
###end title 24
###begin p 25
###xml 106 111 <span type="species:ncbi:9606">human</span>
MMP-2, MMP-9, TIMP-1, and TIMP-2 levels in culture supernatants were assayed using commercially available human MMP and TIMP ELISA test kits (Amersham Biosciences, Bucks, UK) according to the manufacturer's recommendation. The results are expressed as the mean ng/ml +/- standard error (SE) of duplicate assays for five subjects. The minimum detectable levels of these ELISA kits were 0.37 ng/ml for MMP-2, 0.6 ng/ml for MMP-9, 40.0 ng/ml for TIMP-1, and 3.0 ng/ml for TIMP-2, respectively.
###end p 25
###begin title 26
Real-time polymerase chain reaction (PCR)
###end title 26
###begin p 27
###xml 1030 1037 999 1006 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="t1-copd-3-781">Table 1</xref>
mRNA was extracted from fibroblasts using muMACS mRNA isolation kits (Milteny Biotec GmbH, Bergisch Gladbach, Germany) according to the manufacturer's instructions. The first-strand cDNA synthesis from 1.0 mug mRNA was performed using the SuperScript Preamplification System for cDNA synthesis (GIBCO BRL, Gaithersburg, MD, USA). PCR was then carried out using a GeneAmp 5700 Sequence Detection System (Applied Biosystems, Foster City, CA, USA). PCR mixture consisted of 2.0 mul of sample cDNA solution (10.0 ng/mul), 25.0 mul of SYBR-Green Mastermix (Applied Biosystems), 0.3 mul of both sense and antisense primers, and distilled water to give a final volume of 50 mul. The reaction was conducted as follows: 4 min at 95 degreesC, followed by 40 cycles of 15 sec at 95 degreesC and 60 sec at 60 degreesC. beta-actin was amplified as an internal control. mRNA levels were calculated by using the comparative parameter threshold cycle (Ct) and normalized to beta-actin. Oligonucleotide sequences of the primers used were shown in Table 1.
###end p 27
###begin title 28
Assay for NF-kappaB and AP-1 activities
###end title 28
###begin p 29
NF-kappaB activity was analyzed with commercially available ELISA test kits (Active Motif Co. Ltd., Carlsbad, CA, USA) that contained sufficient reagents and monoclonal antibodies against p50 and p65, according to the manufacturer's recommended procedure. In brief, nuclear extract (5.0 mug protein) from LFs was introduced into each well of 96-well microtiter plates pre-coated with oligonucleotide containing the NF-kappaB consensus site (5'-GGGACTTTCC-3') in a volume of 20.0 mul, and incubated for 1 h at 25 degreesC. After washing three times, 100 mul of monoclonal antibody against p50 or p65 was added to the appropriate wells, and incubated for a further 1 h at 25 degreesC. Anti-IgG HRP-conjugate in a volume of 100 mul was then added and incubated 1 h at 25 degreesC. Absorbance at 450 nm was measured after the addition of tetramethylbenzine solution. AP-1 activity was also examined using a commercially available ELISA test kit (Active Motif, Co., Ltd), which contains sufficient reagents and monoclonal antibodies against Fra 2 and Jun B, according to the manufacturer's instructions. Using the manufacturer's data sheet, the amount of NF-kappaB and AP-1, bound to DNA can be measured by these two ELISA systems.
###end p 29
###begin title 30
Statistical analysis
###end title 30
###begin p 31
###xml 148 149 148 149 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
The statistical significance of the difference between the control and experimental data was analyzed using ANOVA followed by Fisher's PLSD test. A p value < 0.05 was accepted as statistically significant.
###end p 31
###begin title 32
Results
###end title 32
###begin title 33
Influence of TBH on MMP-2, MMP-9, TIMP-1, and TIMP-2 production from LFs
###end title 33
###begin p 34
###xml 153 154 149 150 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">5</sup>
###xml 340 348 332 340 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="f1-copd-3-781">Figure 1</xref>
###xml 872 882 852 862 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="f2-copd-3-781">Figures 2a</xref>
The first set of experiments was undertaken to examine the influence of TBH on MMPs production from LFs in response to TNF-alpha stimulation. LFs (5 x 105 cells/ml) was stimulated with 25.0 ng/ml TNF-alpha in the presence of 0, 5, 15, 20, 25, or 50 pg/ml TBH for 24 h. MMPs levels in culture supernatants were assayed by ELISA. As shown in Figure 1, TBH suppressed MMP-2 production from LFs, which is enhanced by TNF-alpha stimulation. The minimum concentration of the agent, which caused significant suppression of MMP-2 production was 15 pg/ml. On the other hand, TNF-alpha stimulation could not induce MMP-9 production from LF; culture supernatants contained undetectable levels (<0.6 ng/ml) of MMP-9 by ELISA (data not shown). We next examined the influence of TBH on the production of both TIMP-1 and TIMP-2 from LFs in response to TNF-alpha stimulation. As shown in Figures 2a and b, TBH could not suppress the ability of LFs to produce TIMP-1 and TIMP-2 from LFs, even when 50 pg/ml of the agent was added to cell cultures.
###end p 34
###begin title 35
Influence of TBH on MMP and TIMP mRNA expression in LFs
###end title 35
###begin p 36
###xml 145 146 145 146 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">5</sup>
###xml 428 436 424 432 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="f3-copd-3-781">Figure 3</xref>
###xml 508 524 504 520 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="f4-copd-3-781">Figures 4a and b</xref>
The second set of experiments was undertaken to examine the influence of TBH on mRNA expression for MMP-2, TIMP-1, and TIMP-2 in LFs. LFs (5 x 105 cells/ml) were stimulated with 25.0 ng/ml TNF-alpha in the presence of 0, 5, 15, 20, or 25 pg/ml TBH for 4 h. Levels of mRNA expression were evaluated by real-time PCR. Addition of TBH at more than 15 pg/ml into cell cultures significantly suppressed MMP-2 mRNA expression in LFs (Figure 3). However, TBH could not reduce levels of TIMP mRNA expression in LFs (Figures 4a and b).
###end p 36
###begin title 37
Influence of TBH on transcription factor activation in LFs
###end title 37
###begin p 38
###xml 149 150 145 146 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">5</sup>
###xml 393 401 381 389 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="f5-copd-3-781">Figure 5</xref>
###xml 677 685 657 665 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="f6-copd-3-781">Figure 6</xref>
The third set of experiments was designed to examine the influence of TBH on transcription factor, NF-kappaB and AP-1, activation in LFs. LFs (5 x 105 cells/ml) were stimulated with 25.0 ng/ml TNF-alpha in the presence of 0, 5, 15, 20, 25, or 50 pg/ml TBH for 4 h. The nuclear extract was prepared, and NF-kappaB activity was assessed by measuring p50 and p65 activities by ELISA. As shown in Figure 5, addition of TBH at more than 15 pg/ml caused significant suppression of p50 and p65 activation in LF, which was induced by TNF-alpha stimulation. On the other hand, TBH could not suppress TNF-alpha stimulated AP-1 activation, as assessed by both Fra-2 and Jun B activities (Figure 6), even when 50.0 ng/ml of the agent was added to cell cultures.
###end p 38
###begin title 39
Discussion
###end title 39
###begin p 40
###xml 564 579 555 570 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b22-copd-3-781">Keam et al 2004</xref>
###xml 511 518 <span type="species:ncbi:9606">patient</span>
###xml 710 718 <span type="species:ncbi:9606">patients</span>
The present results clearly demonstrated that TBH at more than 15 pg/ml could suppress the production of MMP-2 from LFs with virtually no effect on the production of TIMP-1 and TIMP-2. In addition, this inhibitory action of TBH on MMP production is due, in part, to its suppressive effect on MMP mRNA expression through the inhibition of transcription factor NF-kappaB activation by TNF-alpha stimulation. After oral inhalation of TBH, plasma drug levels was gradually increased, plateued at 16 ng/ml when COPD patient was treated with 18.0 mug TBH for 2-3 weeks (Keam et al 2004), suggesting that suppression of MMP-2 production may be occurred in both airways and peripheral lung tissues of TBH-treated COPD patients.
###end p 40
###begin p 41
###xml 318 334 318 334 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b13-copd-3-781">Hamid et al 2004</xref>
###xml 336 351 336 351 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b15-copd-3-781">Hogg et al 2004</xref>
###xml 353 365 353 365 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b20-copd-3-781">Jeffery 2004</xref>
###xml 530 546 530 546 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b13-copd-3-781">Hamid et al 2004</xref>
###xml 548 563 548 563 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b15-copd-3-781">Hogg et al 2004</xref>
###xml 565 577 565 577 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b20-copd-3-781">Jeffery 2004</xref>
###xml 905 923 905 923 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b6-copd-3-781">Demedts et al 2005</xref>
###xml 1063 1081 1063 1081 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b6-copd-3-781">Demedts et al 2005</xref>
###xml 1105 1123 1105 1123 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b23-copd-3-781">Lagente et al 2005</xref>
###xml 1125 1144 1125 1144 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b1-copd-3-781">Babusyte et al 2007</xref>
###xml 1146 1163 1146 1163 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b25-copd-3-781">Lowrey et al 2008</xref>
###xml 1189 1191 1189 1191 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2+</sup>
###xml 1205 1207 1205 1207 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2+</sup>
###xml 1482 1500 1482 1500 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b23-copd-3-781">Lagente et al 2005</xref>
###xml 1598 1622 1598 1622 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b40-copd-3-781">Segura-Valdez et al 2000</xref>
###xml 1624 1642 1624 1642 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b2-copd-3-781">Baraldo et al 2007</xref>
###xml 1644 1661 1644 1661 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b25-copd-3-781">Lowrey et al 2008</xref>
###xml 1774 1792 1774 1792 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b32-copd-3-781">Ohnishi et al 1998</xref>
###xml 1960 1975 1960 1975 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b19-copd-3-781">Imai et al 2001</xref>
###xml 2306 2317 2302 2313 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b30-copd-3-781">Nagase 1997</xref>
###xml 1940 1948 <span type="species:ncbi:9606">patients</span>
COPD is a chronic lung disease, which is mainly induced by inhalation of cigarette smoke, resulting in irreversible airway limitation. A common feature of the disease is the chronic inflammation with intense infiltration of inflammatory cells, especially neutrophils, macrophages and T cells in the airways and lungs (Hamid et al 2004; Hogg et al 2004; Jeffery 2004). Histological observation also revealed structural abnormalities, including thickening of the basement membrane, structural fibrosis and mucous gland hyperplasia (Hamid et al 2004; Hogg et al 2004; Jeffery 2004). These cellular events are now called tissue remodeling, and are involved in an extensive alteration of ECM, which is essential for supporting normal lung functions (Elkington et al 2006). It is also reported that, in some cases of COPD, this tissue remodeling causes destruction of healthy lung tissue, leading to emphysema (Demedts et al 2005). Consideration of the biochemistry of the lung matrix predicts that the MMP family of enzymes is likely to be involved in this pathology (Demedts et al 2005; Elkington et al 2005; Lagente et al 2005; Babusyte et al 2007; Lowrey et al 2008). MMPs are a family of Ca2+-activated, Zn2+-dependent proteases that can degrade various components of the ECM and basement membrane. MMPs are classified on the basis of substrate specificity into collagens (MMP-1, and -8), gelatinase (MMP-2 and -9), and elastases (MMP-7 and -12), among others (Elkington et al 2005; Lagente et al 2005). In an analysis of MMPs expression in COPD, MMP-1, -2, -8, and -9 were found to be upregulated (Segura-Valdez et al 2000; Baraldo et al 2007; Lowrey et al 2008). Immunohistochemical analysis has also demonstrated increased MMP-14 expression in emphysematous lung tissues (Ohnishi et al 1998). Furthermore, the studies combining ELISA, immunocytochemistry and a collagen degradation assay revealed the increased levels of MMP-1 and -12 in patients with COPD (Imai et al 2001). From these reports, it is possible that the attenuating effect of TBH on MMP-2 production from LFs induced by TNF-alpha stimulation may be additional beneficial therapeutic effects not directly relating to its bronchodilatory effects. The extracellular activity of MMPs is regulated by TIMPs that form an 1:1 complex with MMPs (Nagase 1997). The present results clearly showed that TBH could not inhibit the TIMP-1 and -2 production from LFs after TNF-alpha stimulation, suggesting that MMP-2 secreted in small amounts from LFs during TBH treatment are inactivated by TIMPs, and resulting in modification of clinical symptoms derived from ECM remodeling and accumulation of inflammatory cells in COPD.
###end p 41
###begin p 42
###xml 440 442 428 430 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2+</sup>
###xml 481 498 469 486 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b24-copd-3-781">Lazaar et al 1998</xref>
###xml 605 623 589 607 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b45-copd-3-781">Wasylyk et al 1991</xref>
###xml 625 640 609 624 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b38-copd-3-781">Sato et al 1993</xref>
###xml 642 660 626 644 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b34-copd-3-781">Okamoto et al 1994</xref>
###xml 784 786 768 770 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2+</sup>
###xml 871 879 855 863 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 881 897 865 881 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b18-copd-3-781">Ikeda et al 2002</xref>
###xml 1063 1064 1047 1048 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sub>
###xml 1113 1115 1097 1099 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2+</sup>
###xml 1185 1202 1169 1186 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b33-copd-3-781">Ohtake et al 2004</xref>
###xml 1390 1407 1374 1391 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b26-copd-3-781">Martin et al 2004</xref>
###xml 1515 1517 1499 1501 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2+</sup>
###xml 1987 2004 1955 1972 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b42-copd-3-781">Turner et al 2005</xref>
###xml 2153 2174 2113 2134 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b3-copd-3-781">Barchowsky et al 2000</xref>
###xml 2195 2209 2155 2169 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b31-copd-3-781">Nee et al 2007</xref>
###xml 2694 2712 2642 2660 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b36-copd-3-781">Profita et al 2008</xref>
###xml 2932 2950 2876 2894 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b27-copd-3-781">Meriane et al 2006</xref>
###xml 3041 3058 2981 2998 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b17-copd-3-781">Hunter et al 2006</xref>
###xml 3060 3075 3000 3015 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b29-copd-3-781">Mong et al 2008</xref>
###xml 3179 3197 3115 3133 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b44-copd-3-781">Ventura et al 2003</xref>
###xml 3199 3214 3135 3150 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b29-copd-3-781">Mong et al 2008</xref>
###xml 803 813 <span type="species:ncbi:10141">guinea pig</span>
###xml 838 844 <span type="species:ncbi:10090">murine</span>
###xml 1126 1129 <span type="species:ncbi:10116">rat</span>
###xml 1344 1347 <span type="species:ncbi:10116">rat</span>
Although the present results clearly showed the suppressive effect of TBH on MMP production from LFs induced by TNF-alpha stimulation, the mechanisms by which TBH could suppress MMP production are not well understood. TNF-alpha is a multifunctional cytokine that plays a role in inflammation, immunity and a variety of diseases. It is also reported that binding of TNF-alpha to the type-1 TNF receptor causes an increase in intracellular Ca2+ concentration through calcium influx (Lazaar et al 1998), and results in activation of NF-kappaB, which are essential transcription factors for MMP-2 production (Wasylyk et al 1991; Sato et al 1993; Okamoto et al 1994). Solifenacin succinate, a newly developed muscarinic receptor antagonist, could inhibit carbachol-induced intracellular Ca2+ mobilization in guinea pig smooth muscle cells and murine submandibular gland cells in vitro (Ikeda et al 2002). Soliferan succinate and the other antimuscarinic drugs, such as darifenacin and oxybutynin chloride, which receptor, are also have higher affinity for muscarinic M3 reported to inhibit increase in intracellular Ca2+ levels in rat salivary gland cells induced by carbachol stimulation (Ohtake et al 2004). Furthermore, otilonium bromide, a muscarinic receptor antagonist, could inhibit the increase in intracellular calcium levels in cells from rat colon by blocking L-type calcium channel (Martin et al 2004). Judging from these reports, it is possible that addition of TBH into LFs cultures caused inhibition of Ca2+mobilization induced by TNF-alpha stimulation, and resulted in suppression of MMP-2 production through the inhibition of transcription factor, especially NF-kappaB, activation. On the other hand, TNF-alpha-induced gene transcription in many cell types is mediated by a number of signal transduction pathways, including those involving extracellular signal-regulated kinase (ERK), mitogen activated protein-kinase (MAPK), Jun N-terminal kinase (JUN), NF-kappaB and AP-1 (Turner et al 2005). In these pathways, activation of ERK and MAPK is essential for TNF-alpha-mediated MMP gene expression in fibroblasts after TNF-alpha stimulation (Barchowsky et al 2000; Domeij et al 2002; Nee et al 2007). From these reports and the present results showing that the inhibitory action of TBH on the NF-kappaB activation may suggest that TBH inhibits ERK and MPK activation and results in suppression of MMP production in LFs after TNF-alpha stimulation. This speculation may be supported, in part, by the observation that muscarinic receptor antagonists could prevent inflammatory protein production induced by acetylcholine stimulation through the inhibition of ERK-NF-kappaB activation (Profita et al 2008). In addition to the above mentioned signal transduction pathways, TNF-alpha stimulation causes RhoA/Rho kinase activation, which is responsible for the production of MMP-9 and transmembrane metalloproteinase, MT1-MMP (Meriane et al 2006), through enhancement of JNK activation in endothelial cells after TNF-alpha stimulation (Hunter et al 2006; Mong et al 2008). It is also reported that AP-1 up-regulation induced by TNF-alpha simulation requires JNK activation (Ventura et al 2003; Mong et al 2008). From these reports, there is a possibility that TBH may directly inhibit up-regulation of RhoA/Rho kinase induced by TNF-alpha stimulation in LFs and results in suppression of MMP-2 production, since TBH could not suppress AP-1 activation by TNF-alpha stimulation in LFs. Anyway, further experiments are required to clarify the mechanisms by which TBH inhibits MMP-2 production from LFs in response to TNF-alpha stimulation.
###end p 42
###begin p 43
###xml 149 164 149 164 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b39-copd-3-781">Sato et al 2002</xref>
Different from MMPs, PEA3, a protooncogene-related transcriptional factor, is involved in the regulation of TIMP transcription (De Clerk et al 1994; Sato et al 2002). From these reports, the present results may be interpreted that TBH could not inhibit PEA3 activation by TNF-alpha stimulation and results in negative suppressive effects on TIMP production from LFs.
###end p 43
###begin p 44
###xml 244 262 244 262 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b16-copd-3-781">Hoshino et al 1998</xref>
###xml 264 281 264 281 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b14-copd-3-781">Herouy et al 2001</xref>
###xml 401 419 401 419 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b16-copd-3-781">Hoshino et al 1998</xref>
###xml 421 438 421 438 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b14-copd-3-781">Herouy et al 2001</xref>
###xml 886 903 886 903 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b35-copd-3-781">Powrie et al 2007</xref>
###xml 489 497 <span type="species:ncbi:9606">patients</span>
###xml 835 842 <span type="species:ncbi:9606">patient</span>
###xml 876 884 <span type="species:ncbi:9606">patients</span>
MMPs are produced by numerous cell types, including fibroblast, macrophages and neutrophils in response to inflammatory stimulation, and mediated transmigration of the inflammatory cells through the basement membrane to propagate inflammation (Hoshino et al 1998; Herouy et al 2001). MMPs are also responsible for microvascular permeability leading to oedema and enhanced inflammatory cell migration (Hoshino et al 1998; Herouy et al 2001), suggesting that administration of TBH into COPD patients attenuates inflammatory responses in the airways and lungs, and may result in favorable modification of clinical status of COPD, including exacerbation frequency. However, a recent report showed that TBH therapy for one year could not reduce the levels of inflammatory makers, such as IL-6, IL-8, and myeloperoxidase in sputum from COPD patient as compared with placebo-treated patients (Powrie et al 2007). The reasons for this discrepancy are not clear at present. TBH is well accepted to be able to potentially inhibit cholinergic stimulation of mucus-secreting goblet cells in the airways to cause reduction in total volume of sputum, resulting in increase in protein levels in sputum. This may be responsible for negative suppressive effect of TBH on inflammatory marker levels in sputum.
###end p 44
###begin p 45
###xml 292 300 <span type="species:ncbi:9606">patients</span>
Finally, this is the first report showing that TBH exerts suppressive effect on MMP production from lung fibroblasts induced by an inflammatory stimulation, and this suppressive activity of TBH may be additional beneficial effects not directly relating to its bronchodilatory effects in COPD patients.
###end p 45
###begin title 46
References
###end title 46
###begin article-title 47
Patterns of airway inflammation and MMP-12 expression in smokers and ex-smokers with COPD
###end article-title 47
###begin article-title 48
Matrix metalloproteinase-2 protein in lung periphery is related to COPD progression
###end article-title 48
###begin article-title 49
###xml 171 177 <span type="species:ncbi:9986">rabbit</span>
Intergration of the NF-kappaB and mitogen-activated protein kinase/AP-1 pathway at the collagenase-1 promotor: divergence of IL-1 and TNF-dependent signal transduction in rabbit primary synovial fibroblasts
###end article-title 49
###begin article-title 50
A long-term evaluation of once-daily inhaled tiotropium in chronic obstructive pulmonary disease
###end article-title 50
###begin article-title 51
###xml 66 74 <span type="species:ncbi:9606">patients</span>
MMP-2- and MMP-9-linked gelatinolytic activity in the sputum from patients with asthma and chronic obstructive pulmonary disease
###end article-title 51
###begin article-title 52
Matrix metalloproteinases in asthma and COPD
###end article-title 52
###begin article-title 53
###xml 54 59 <span type="species:ncbi:9606">human</span>
Characterization of the promotor of the gene encoding human tissue inhibitor of metalloproteinase-2 (TIMP-2)
###end article-title 53
###begin article-title 54
###xml 65 70 <span type="species:ncbi:9606">human</span>
Signal pathways involved in the production of MMP-1 and MMP-3 in human gingival fibroblasts
###end article-title 54
###begin article-title 55
Antimuscarinic treatment for lung diseases from research to clinical practice
###end article-title 55
###begin article-title 56
###xml 57 65 <span type="species:ncbi:9606">patients</span>
The effect of tiotropium on exacerbations and airflow in patients with COPD
###end article-title 56
###begin article-title 57
Matrix metalloproteinases in destructive pulmonary pathology
###end article-title 57
###begin article-title 58
Protective effects of tiotropium bromide in the progression of airway smooth muscle remodeling
###end article-title 58
###begin article-title 59
Inflammation and remodeling in chronic obstructive pulmonary diseases
###end article-title 59
###begin article-title 60
Inflammation in stasis dermatitis upregulates MMP-1, MMP-2, and MMP-13 expression
###end article-title 60
###begin article-title 61
The nature of small-airway obstruction in chronic obstructive pulmonary disease
###end article-title 61
###begin article-title 62
Bronchial subepithelial fibrosis and expression of matrix metalloproteinase-9 in asthmatic airway inflammation
###end article-title 62
###begin article-title 63
###xml 103 108 <span type="species:ncbi:9606">human</span>
Spatial compartmentalization of tumor necrosis factor (TNF) receptor 1-dependent signaling pathways in human airway smooth muscle cells: lipid rafts are essential for TNF-alpha-mediated activation of RhoA but dispensable for the activation of the NF-kappaB and MAPK pathways
###end article-title 63
###begin article-title 64
M3 receptor antagonism by the novel antimuscarinic agent solifenacin in the urinary bladder and salivary gland
###end article-title 64
###begin article-title 65
###xml 0 5 <span type="species:ncbi:9606">Human</span>
###xml 74 82 <span type="species:ncbi:9606">patients</span>
Human collagenase (matrix metalloproteinase-1) expression in the lungs of patients with emphysema
###end article-title 65
###begin article-title 66
Remodeling and inflammation of bronchi in asthma and chronic obstructive pulmonary disease
###end article-title 66
###begin article-title 67
Lung matrix metalloproteinase-9 correlates with cigarette smoking and obstruction of airflow
###end article-title 67
###begin article-title 68
###xml 66 74 <span type="species:ncbi:9606">patients</span>
Tiotropium bromide. A review of its use as maintenance therapy in patients with COPD
###end article-title 68
###begin article-title 69
Role of matrix metalloproteinases in the development of airway inflammation and remodeling
###end article-title 69
###begin article-title 70
###xml 37 42 <span type="species:ncbi:9606">human</span>
CD40-mediated signal transduction in human airway amooth muscle
###end article-title 70
###begin article-title 71
###xml 76 84 <span type="species:ncbi:9606">patients</span>
MMP-9 protein level does not reflect overall MMP activity in the airways of patients with COPD
###end article-title 71
###begin article-title 72
###xml 82 85 <span type="species:ncbi:10116">rat</span>
Otilonium bromide inhibits muscle contractions via L-type calcium channels in the rat colon
###end article-title 72
###begin article-title 73
Cooperation of matrix metalloproteinases with the RhoA/Rho kinase and mitogen-activated protein kinase: Kinase-1/extracellular signal-regulated kinase signaling pathways is required for the shingosine-1-phosphate-induced mobilization of marrow-derived stroma cells
###end article-title 73
###begin article-title 74
The matrix metalloproteinases and their inhibitors
###end article-title 74
###begin article-title 75
###xml 72 77 <span type="species:ncbi:9606">human</span>
Activation of Rho Kinase by TNF-alpha is required for JNK activation in human pulmonary microvascular endothelial cells
###end article-title 75
###begin article-title 76
Activation mechanisms of matrix metalloproteinase
###end article-title 76
###begin article-title 77
###xml 67 72 <span type="species:ncbi:9606">human</span>
TNF-alpha and IL-1 beta-mediated regulation of MMP-9 and TIMP-1 in human glomelular mesangial cells
###end article-title 77
###begin article-title 78
###xml 78 83 <span type="species:ncbi:9606">human</span>
Matrix-metalloproteinase-mediated extracellular matrix protein degradation in human pulmonary emphysema
###end article-title 78
###begin article-title 79
###xml 124 128 <span type="species:ncbi:10116">rats</span>
In vitro and in vivo tissue selectivity profile of solifenacin succinate (YM905) for urinary bladder over salivary gland in rats
###end article-title 79
###begin article-title 80
The interleukin-8, AP-1 and kB-like sites are genetic end targets of FK-506-sensitive pathway accompanied by calcium mobilization
###end article-title 80
###begin article-title 81
Effect of tiotropium on sputum and serum inflammatory markers and exacerbation in COPD
###end article-title 81
###begin article-title 82
###xml 46 51 <span type="species:ncbi:9606">human</span>
Acetylcholine mediates the release of IL-9 in human bronchial epithelial cells by a NFkappaB/ERK-dependent mechanism
###end article-title 82
###begin article-title 83
Tiotropium for the treatment of stable chronic obstructive pulmonary diseases: a systemic review with meta-analysis
###end article-title 83
###begin article-title 84
Regulation of 92 kDa type IV collagenase gene expression which is associated with invasiveness of tumor cells
###end article-title 84
###begin article-title 85
###xml 270 275 <span type="species:ncbi:9606">human</span>
Inhibition of activator protein-1 binding activity and phosphatidylinositol 3-kinase pathway by a polymethoxy flavonoid, results in augmentation of tissue inhibitor of mettaloproteinase-2 production and suppression of production of matrix metalloproteinases-2 and -9 in human fibrosarcoma HT-1080 cells
###end article-title 85
###begin article-title 86
Upregulation of elatinases A and B, collagenases 1 and 2, and increased parenchymal cell death in COPD
###end article-title 86
###begin article-title 87
###xml 92 100 92 100 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
Influence of roxithromycin on inflammatory cytokine production from nasal polyp fibroblasts in vitro
###end article-title 87
###begin article-title 88
###xml 42 47 <span type="species:ncbi:9606">human</span>
Simvastatin inhibits MMP-9 secretion from human saphenous vein smooth muscle cells by inhibiting the Rho/ROCK pathway and reducing MMP-9 mRNA levels
###end article-title 88
###begin article-title 89
###xml 28 36 <span type="species:ncbi:9606">patients</span>
Improved health outcomes in patients with COPD during 1yr's treatment with tiotropium
###end article-title 89
###begin article-title 90
c-Jun NH2-terminal kinase is essential for the regulation of AP-1 by tumor necrosis factor
###end article-title 90
###begin article-title 91
The c-Ets oncoprotein activates the stromelysin prompter through the same elements as several non-nuclear oncoprotein
###end article-title 91
###begin p 92
###xml 157 158 153 154 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">5</sup>
Influence of tiotropium on metalloproteinase (MMP)-2 production from lung fibroblasts induced by tumor necrosis factor (TNF)-alpha stimulation. Cells (5 x 105 cells/ml) were stimulated with 25.0 ng/ml TNF-alpha in the presence of various concentrations of tiotropium for 24 h. MMP-2 levels in culture supernatants were examined by ELISA. Data are expressed as the mean ng/ml + SE of five different subjects.
###end p 92
###begin p 93
###xml 0 6 0 6 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Notes:</bold>
Notes: *significant (P < 0.05) as compared with TNF alone.
###end p 93
###begin p 94
###xml 93 94 93 94 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">a</bold>
###xml 108 109 108 109 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">b</bold>
###xml 208 209 204 205 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">5</sup>
Influence of tiotropium on the production of tissue inhibitor of metalloproteinase (TIMP)-1 (a) and TIMP-2 (b) from lung fibroblasts in response to tumor necrosis factor (TNF)-alpha stimulation. Cells (5 x 105 cells/ml) were stimulated with 25.0 ng/ml TNF-alpha in the presence of various concentrations of tiotropium for 24 h. TIMP-1 and TIMP-2 levels in culture supernatants were examined by ELISA. Data are expressed as the mean ng/ml + SE of five different subjects.
###end p 94
###begin p 95
###xml 162 163 158 159 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">5</sup>
Influence of tiotropuim on matrix metalloproteinase (MMP)-2 mRNA expression in lung fibroblasts after tumor necrosis factor (TNF)-alpha stimulation. Cells (5 x 105 cells/ml) were stimulated with 25.0 ng/ml TNF-alpha in the presence of various concentrations of tiotropium for 4h. mRNA expression was examined by real-time RT-PCR. Data are expressed as the mean ratio + SE of five different subjects.
###end p 95
###begin p 96
###xml 0 6 0 6 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Notes:</bold>
Notes: *significant (P < 0.05) as compared with TNF alone.
###end p 96
###begin p 97
###xml 96 97 96 97 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">a</bold>
###xml 111 112 111 112 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">b</bold>
###xml 209 210 205 206 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">5</sup>
Influence of tiotropium on mRNA expression for tissue inhibitor of metalloproteinases (TIMP)-1 (a) and TIMP-2 (b) in lung fibroblasts in response to tumor necrosis factor (TNF)-alpha stimulation. Cells (5 x 105 cells/ml) were stimulated with 25.0 ng/ml TNF-alpha in the presence of various concentrations of tiotropium for 4 h. mRNA expression was examined by real-time RT-PCR. Data are expressed as the mean ratio + SE of five different subjects.
###end p 97
###begin p 98
###xml 156 157 148 149 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">5</sup>
Influence of tiotropium on nuclear factor (NF)-kappaB activation in lung fibroblasts induced by tumor necrosis factor (TNF)-alpha stimulation. Cells (5 x 105 cells/ml) were stimulated with 25.0 ng/ml TNF-alpha in the presence of various concentrations of tiotropium for 4 h. NF-kappaB, p-50 and p-65, activities were assayed by ELISA. Data are expressed as the mean optical density (OD) at 450 nm + SE of five different subjects.
###end p 98
###begin p 99
###xml 0 6 0 6 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Notes:</bold>
Notes: *significant (P < 0.05) as compared with TNF alone.
###end p 99
###begin p 100
###xml 155 156 151 152 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">5</sup>
Influence of tiotropium on activator protein (AP)-1 activation in lung fibroblasts induced by tumor necrosis factor (TNF)- alpha stimulation. Cells (5 x 105 cells/ml) were stimulated with 25.0 ng/ml TNF-alpha in the presence of various concentrations of tiotropium for 4 h. AP-1, Fra 2 and Jun B, activities were assayed by ELISA. Data are expressed as the mean optical density (OD) at 450 nm + SE of five different subjects.
###end p 100
###begin p 101
Primer sequences used for real-time polymerase chain reaction
###end p 101

